Figure 3 from A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors

<p>Tumor burden changes. Of the 22 patients treated, 15 (68.2%) patients were evaluable for response.</p>

Сохранить в:

Библиографические подробности
Главный автор:	Lillian L. Siu (14851075) (author)
Другие авторы:	Timothy A. Yap (15028749) (author), Sofia Genta (16724385) (author), Gregory Pennock (22547938) (author), Christine Hicking (18559919) (author), Deepthi S. Vagge (22547941) (author), Jatinder Kaur Mukker (18559913) (author), Giuseppe Locatelli (18559922) (author), Anthony W. Tolcher (18559910) (author)
Опубликовано:	2025
Предметы:	Cancer Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Biomarkers Clinical Trial Results Phase I clinical trials Drug Targets
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы